Technology
Upcoming Earnings
Health

Forty Seven

$18.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-0.92%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Forty Seven and other stocks, options, ETFs, and crypto commission-free!

About

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. Read More The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Employees
43
Headquarters
Menlo Park, California
Founded
2014
Market Cap
570.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
140.66K
High Today
$18.82
Low Today
$17.91
Open Price
$18.82
Volume
215.52K
52 Week High
$23.83
52 Week Low
$12.02

Collections

Technology
Upcoming Earnings
Health
Pharmaceutical
Cancer Prevention
Medical
2018 IPO
US

News

Seeking AlphaMar 11

March Outlook For Forty Seven Inc.

On the technical side, FTSV may have hit its trading ceiling (absent of clinical updates) and may be due for a correction unless there's more trial news that's positive.

608
MarketBeatFeb 19

Stock Price, News, & Analysis for Forty Seven

News articles about FTSV stock have been trending very positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Forty Seven earned a news impact score of 4.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 8.0 out of 10, indicating that rec...

181

Earnings

-$0.71
-$0.65
-$0.60
-$0.54
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.65 per share
Actual
Expected Mar 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.